ArticleFrontiers in pediatrics2023

Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.

Elizabeth D Slaney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.